Press "Enter" to skip to content

Lupin launches generic drug used for prevention of organ rejection in kidney transplant in US

Drug firm Lupin on Monday said it has launched generic Mycophenolic acid delayed-release tablets, which is used to prevent organ rejection in patients receiving kidney transplants in the US market.

Leave your comments

%d bloggers like this: